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ABSTRACT

CONTRIBUTION OF A CLASS II RIBONUCLEOTIDE REDUCTASE TO THE
MANGANESE DEPENDENCE OF Streptococcus sanguinis

By John Lee Smith

A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University

Virginia Commonwealth University
Richmond, VA
June 2017

Principal Investigator: Dr. Todd Kitten
Associate Professor of Oral and Craniofacial Molecular Biology
and of Microbiology and Immunology

Manganese-deficient Streptococcus sanguinis mutants exhibit a dramatic
decrease in virulence for infective endocarditis and in aerobic growth in manganeselimited media. Loss of activity of a manganese-dependent, oxygen-dependent

xiii

ribonucleotide reductase (RNR) could explain the decrease in virulence. When the
genes encoding this RNR are deleted, there is no growth of the mutant in aerobic broth
culture or in an animal model. Testing the contribution of the aerobic RNR to the
phenotype of a manganese transporter mutant, a heterologous class II RNR from
Lactobacillus leichmannii called NrdJ that requires B12 rather than manganese as a
cofactor was previously introduced into an RNR mutant of S. sanguinis. Aerobic growth
was only partially restored. Currently, we sought to improve NrdJ-dependent growth by
(i) amending the medium to increase cellular levels of B12; (ii) characterizing a
spontaneous mutant of the NrdJ-complemented strain with improved aerobic growth;
and (iii) altering this strain through further genetic manipulation.

xiv

I. INTRODUCTION

A. Streptococci
In 1874 an Austrian surgeon, Theodor Billroth, first described a streptococcal
infection in erysipelas, a bacterial infection of the outer layer of the skin which is usually
associated with a skin rash and wound infections (1,2). He described the bacteria
observed as streptococci meaning a chain (strepto) and berry (coccus). In 1879
streptococci became officially known due to Louis Pasteur and his isolation of the
causative agent of the disease puerperal fever (3). Puerperal fever is a postpartum
infection that was often fatal during this time period (4).
In 1903, Hugo Schottmuller created the blood agar plate that helped to
differentiate streptococci (5,6). His work was in differentiating between hemolytic and
nonhemolytic strains of the bacteria (21). James Howard Brown described the three
types of hemolytic patterns in 1919. An alpha hemolytic pattern is a green zone of
discoloration, whereas a beta hemolytic pattern is a clear zone and a gamma hemolytic
pattern indicates no change. Alpha patterns were characteristic of viridans streptococci,
beta were characteristic of S. haemolyticus type organisms and gamma were
characteristic of enterococci (4).
In 1933, Rebecca Lancefield reported a method of differentiating beta-hemolytic
streptococcal strains. The method worked by categorizing the Streptococcus based on
the carbohydrate composition of the antigens in the cell wall (21). Building on this work
J. M. Sherman further broke down streptococci into four groups. They were viridans,
enterococci, lactic and pyogenic groups (8). These groups, still used today, were based
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on hemolytic reaction, Lancefield grouping, and phenotypic tests, primarily fermentation
and tolerance (21).
The streptococcal species that were placed in the pyogenic division were betahemolytic with the Lancefield groupings A, B, C, E, F, and G. This system has not
changed significantly with the modern serotyping (22). The lactic division encompassed
all the strains that were associated primarily with the manufacturing of dairy products.
These strains were renamed Lactococcus in the 1930s. The traditional lactic group was
not beta-hemolytic and grew at 10°C. It did not grow at 45°C and also failed to grow at
6.5% NaCl. The strains were not associated with human infections but with the
reclassification there have been newly discovered strains that do infect humans (22).
Enterococci exhibit varied beta-hemolysis. However, those that are in this division are
tolerant to high pH, high salt concentration and grow from temperatures as low as 10°C
and as high as 45°C (22). Finally, viridans streptococcus strains are not beta-hemolytic
and are not able to grow in high-pH conditions, nor can they grow on high salt
concentrations or at 10°C (22).
Historically, the classification of bacterial isolates has been dependent on
morphological and phenotypic similarities with type strains. However, this method of
categorizing bacteria was less than perfect. In the 1980s, laboratories of Woese and
others were starting to use the stable genetic codes found in the 5S, 16S, 23S rRNA
and the spaces between these genes to start to classify bacteria genetically (23). The
16S rRNA is now the genetic area that is most often used in taxonomy of bacteria (23).
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B. Viridans streptococci
Viridans streptococci are gram positive cocci arranged in chains. They are
catalase-negative, leucine aminopeptide positive, pyrrolidonylarylamidase negative and
have no growth in 6.5% NaCl broth. Viridans streptococci received their name from their
green color in response to the alpha-hemolysis that occurs on blood agar. However,
because not all of the viridans streptococci perform alpha-hemolysis, this group is also
known as oral streptococci. This name also does not accurately describe the group
since some species come from the gastrointestinal, vaginal and dairy product sources
(21). Viridans is further divided into five subcategories. These are the Streptococcus
mutans group, Streptococcus salivarius group, Streptococcus anginosus group,
Streptococcus mitis group and Streptococcus sanguinis group (formerly S. sanguis)
(21).

C. Streptococcus sanguinis
Streptococcus sanguinis was previously called Streptococcus sanguis. In 1997,
Streptococcus sanguis, meaning “the blood”, was changed to the more grammatically
correct Streptococcus sanguinis, meaning “of the blood” (9). Streptococcus sanguinis is
a gram-positive, facultative anaerobe and normally found in the human mouth (16).
As a primary colonizer of the mouth, in infants S. sanguinis is the first bacterium to
emerge within the oral cavity and it correlates to the emergence of the first tooth, at
around nine months of age (10). In adults, during the first four hours after a professional
cleaning, the majority of the cultivable bacteria are streptococci (11). S. sanguinis
adheres to components within the salivary pellicle, which is a thin coating that covers
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the tooth surface. Many of the components consist of glycoproteins, mucins and
enzymes found in saliva (12).
If nothing else, S. sanguinis could be described as a benign indicator of a healthy
oral cavity. At its best, S. sanguinis could be a beneficial bacterium in the mouth (10). S.
sanguinis has an antagonistic interaction with Streptococcus mutans, a well-known
cause of caries within the oral cavity (13). S. sanguinis produces hydrogen peroxide that
impedes the growth of S. mutans, so a high ratio of S. mutans to S. sanguinis is a
common indicator of poor health in the mouth (13).
An unfortunate truth is that oral streptococci and staphylococci account for most
cases of infective endocarditis if they enter the bloodstream (14). S. sanguinis is
commonly the culprit for causing infective endocarditis from the viridans species (15).

D. Infective Endocarditis
Infective endocarditis, when caused by S. sanguinis, is commonly categorized as
a native-valve infective endocarditis (NVE) (14, 16). Native-valve infective endocarditis
is traditionally associated with congenital heart disease, chronic rheumatic heart
disease and mitral valve prolapse with regurgitation (14, 16). Platelets and fibrin
accumulate on the damaged valve. The result is the formation of a sterile “vegetation.”
Bacteria can then accumulate on top of the platelets and fibrin layer which in turn
attracts monocytes, activating tissue-factor activity (TFA) and cytokines (16). More
platelets and fibrin attach to the bacteria; some of the bacteria seed the bloodstream
and attach to the surface of the newly formed vegetation and the process continues,
supporting additional vegetative growth (16). Infective endocarditis is still a challenging
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disease to manage and continues to have a high mortality rate even with advances in
technology (17). Viridans streptococci are the predominant cause of NVE (55.1%) (19).
In one study, the most common species of oral streptococci leading to infective
endocarditis were Streptococcus sanguis sensu stricto (31.9%), S. oralis (29.8%) and S.
gordonii (12.7%) (18). However, these percentages and species can fluctuate from
study to study. Oral streptococci can enter the bloodstream from dental procedures but
also from eating or basic oral care. This would indicate that antibiotics are not the best
solution and would prompt the need for a vaccine or some other protective measure
(16).

E. Identification of Virulence Determinants of S. sanguinis
Since S. sanguinis causes endocarditis there was a need to discover the genes
that cause virulence that could be used for a potential vaccine or drug target. Signaturetagged mutagenesis (STM) technique was used to search for virulence factors for
endocarditis. Using 800 mutants of S. sanguinis SK36, STM identified 38 putative
avirulent and 5 putative hypervirulent mutants (16). There were six mutants that
appeared to be the most promising. The mutations were in genes encoding
undecaprenol kinase, homoserine kinase, anaerobic ribonucleotide reductase (RNR),
adenylosuccinate lyase, a hypothetical protein and an intergenic region (16).
A surface bound protein would be necessary for a vaccine. Bioinformatics were
used to find 52 putative lipoproteins (20). STM was used to systematically knock out
these lipoproteins one by one. Knockout mutants were then compared to wild-type
SK36 using a competitive index (CI) assay to show whether the mutant was more, less
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or similarly virulent (20). A rabbit model was used for the CI assay. Cardiac
catheterization caused the formation of sterile vegetations and then a 1:1 inoculation of
the wild-type and mutant was injected into the animal model. The vegetation was then
plated and compared to the initial inoculum to create the competitive index ratio.

F. Lipoproteins
Within streptococcal species, lipoproteins have been known to contribute to
virulence, which makes the targeting of lipoproteins a viable vaccine option (20). These
lipoprotein virulence functions include adhesion, posttranslational modification and ATPbinding cassette (ABC) mediated transport (20). Of the 52 putative lipoprotein mutants,
only six were found to have reduced virulence during the STM screen. The six mutated
genes were SSA_0004, SSA_0588, SSA_1122, SSA_1976, SSA_2243, and ssaB.
Along with the six mutants two lipoprotein related genes were tested, lgt and lspA, both
mutants of which also were found to have reduced virulence. Of the eight mutants only
three were significantly less competitive using the competitive index assay, those with
mutations in prolipoprotein diacylglyceryl transferase (lgt) which is a lipoproteinprocessing enzyme, signal peptidase II (lspA) also a lipoprotein-processing enzyme and
a manganese ABC transporter substrate-binding protein (ssaB) (20). Only the ssaB
mutant displayed a signal that had the same signal intensity as the negative control and
had reduced competitiveness in the CI assay. Additionally, the drop in virulence for the
lgt and lspA mutants was only twofold to threefold in the animal model while the ssaB
mutant had a drop of over 1,000-fold (20).
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G. ssaB and ssaACB
The lipoprotein SsaB (SSA_0260) belongs to the lipoprotein receptor antigen I
(LraI) family of conserved metal transporters. LraI operons minimally contain the genes
for an ATP-binding protein (ATPB), an integral membrane protein (IMP) and the LraI
lipoprotein (24). The LraI operon within Streptococcus pneumoniae, Streptococcus
gordonii, Streptococcus parasanguinis, other streptococci and even in a
cyanobacterium are believed to transport Mn and maybe to a lesser extent iron (25, 24).
In addition, ssaR (SSA_0256) which is a MntR, a manganese-dependent transcriptional
regulator, is encoded in close proximity to the LraI operon, ssaACB, in order to repress
the uptake of manganese when it is in abundance (25). The deletion of ssaB or the
more complete deletion of the whole operon, ssaACB, caused a decrease in virulence
and aerobic growth in manganese-limited media, presumably due to the decrease of
manganese that is able to enter the cell (25). Restoration of aerobic growth for the ssaB
mutant was seen with the addition of manganese but not with other divalent metal ions:
iron, cobalt, copper, nickel or zinc (Fe2+, Co2+, Cu2+, Ni2+ or Zn2+) (25).

H. SodA vs ssaB
The deletion of ssaB was seen in vitro to decrease growth in aerobic conditions
but not when oxygen levels are low. The potential reason for this decline could be due
to the decrease in activity of SodA, the manganese-dependent superoxide dismutase
(25). However, deletion of sodA revealed that the sodA mutant is only 10-fold less
competitive than the wild-type in the rabbit model of endocarditis while the ssaB mutant
is over 1000-fold less competitive using a CI assay (25). In an in vitro model using rabbit
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serum at 12% O2, the sodA mutant was decreased by a factor of a 1000 in growth while
the ssaB mutant was decreased by a factor of a 100,000 in growth. This would indicate
that the decrease in virulence with the deletion of ssaB, which causes a decrease in
manganese uptake, is not due solely to loss of SodA activity.

I. Ribonucleotide Reductase (RNR)
1. RNR Classes
One of the major enzymes that uses manganese within Streptococcus sanguinis
is ribonucleotide reductase. Ribonucleotide reductase (RNR) is the only enzyme that
can synthesize deoxyribonucleotide triphosphate (dNTP) through a de novo biochemical
pathway. This enzyme is needed for the conversion of ribonucleotides to
deoxyribonucleotides which is needed for DNA replication and repair (26). There are
three classes of RNR for the conversion of ribonucleotide diphosphates (NDP) or
ribonucleotide triphosphates (NTP) to deoxyribonucleotide diphosphates (dNDP) or
deoxyribonucleotide triphosphates (dNTP) respectively: class I, class II and class III.
Class I is divided into three subgroup classes which are dependent on the metal
cofactor they use (26). Class Ia uses a di-iron center (FeIII-O-FeIII), class Ib uses a dimanganese center (MnIII-O-MnIII) in vivo but was able to work with a di-iron center (FeIIIO-FeIII) in vitro, and class Ic uses a manganese iron center (MnIV-O-FeIII) (26). All three
subgroups convert NDPs to dNDPs and require the presence of oxygen for the
generation of a radical catalyst (26).

8

Class II uses S-adenosylcobalamine (AdoCob), also known as vitamin B12, as a
cofactor to convert both NDP and NTP to dNDP and dNTP respectively. Class II is also
oxygen independent and can be used for both aerobic and anaerobic growth (26).
Class III requires the binding of S-adenosylmethionine (SAM) to an iron-sulfur
cluster ([4Fe-4S]+) to catalyze the reaction from NTP to dNTP. This class is only active
under anaerobic conditions (26). A summary of these RNR classes is illustrated in
Figure 1.
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Figure 1. Overview of the Ribonucleotide Reductase (RNR) classes. Class I RNR
are all aerobic and split into three subclasses. Class Ia uses NrdAB and iron (Fe) is the
metallo-cofactor. Class Ib uses NrdHEKF and manganese (Mn) is the metallo-cofactor
in vivo. The transition of the Mn to a tyrosyl radical needs NrdI. The class Ic uses NrdAB
and the metallo-cofactor is Fe and Mn. Class I RNRs need oxygen to create the tyrosyl
radical to then create the thiyl radical which converts NDP to dNDP. Class II is O2
independent and uses NrdJ. The metallo-cofactor is cobalt (Co) and the enzyme uses
the cofactor adenosylcobalamin (AdoCbl) to create the thiyl radical. Class II RNR can
convert both NDP and NTP to dNDP and dNTP. Class III is strictly anaerobic using
NrdDG. NrdG requires S-adenosylmethionine (SAM) and an iron-sulfur cluster to create
a glycyl radical. NrdD then uses the glycyl radical to create the thiyl radical to convert
NTP to dNTP.
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2. Anaerobic Class III Ribonucleotide Reductase in Streptococcus sanguinis
Streptococcus sanguinis possesses an anaerobic class III RNR (27). The
proteins that comprise the anaerobic class III RNR are NrdD, alpha (α) subunit, and
NrdG, the beta (β) subunit, which must form a homodimer to become active (26). NrdD
has the active site while NrdG is the activase (26) using S-adenosylmethionine (SAM)
and the iron-sulfur cluster ([4Fe-4S]+) to form a glycyl radical (28). NrdDG can only be
formed under strictly anaerobic conditions because the [4Fe-4S]+, glycyl radical, and
SAM rapidly degrade in the presence of oxygen (27). NrdD is permanently inactivated
through the cleavage of the polypeptide chain (27). The class III RNR does not use
manganese and cannot be activated in the presence of oxygen. These two factors
should exclude NrdDG as a possibility for the decrease in virulence when ssaB or
ssaACB are deleted and the mutant is grown aerobically.

3. Aerobic Class Ib Ribonucleotide Reductase in Streptococcus sanguinis
Streptococcus sanguinis possesses an aerobic class Ib RNR which uses Mn in
vivo. The decrease in aerobic virulence upon deletion of the ssaB/ssaACB genes
encoding a Mn transporter, could be related to the aerobic Mn-dependent RNR, which is
encoded by nrdHEKF (26). The α subunit is NrdE while NrdF is the β subunit. Both α
and β each form two homodimeric subunits. The α subunit is the catalytic subunit where
the nucleotide reduction occurs, and the β subunit contains the di-manganese center
(MnII2) that oxidizes a conserved cysteine in the active site of the enzyme to form the
thiyl radical (26, 29). NrdI is a flavodoxin that oxidizes the MnII2-NrdF to the active MnIII2-
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Y• (27, 29). NrdH is a glutaredoxin-like thioredoxin that reduces the disulfide formed by
the conversion of the NDP to dNDP or NTP to dNTP (27). NrdK is a hypothetical protein
of unknown function (27).

4. Class II Ribonucleotide Reductase in Lactobacillus leichmannii
NrdJ is the essential protein for the class II RNR and is comprised of a single αchain polypeptide (26). NrdJ is the α subunit with the active center containing the
allosteric sites of the enzyme, and S-adenosylcobalamin (AdoCob) is used as the “β
subunit” to generate the thiyl radical (26, 27). NrdJ is oxygen-independent and can use
both NDPs and NTPs as substrates (26).

5. Ribonucleotide Reductase Mutants of S. sanguinis
The first RNR mutant was created by replacing nrdHEKF, encoding the class Ib
RNR, with the aphA-3 gene encoding kanamycin resistance (Kanr) and named JFP138
(ΔnrdHEKF) (27). Strains used for this study are listed in Table 1. Additionally, a mutant
was created by replacing nrdI with the aphA-3 gene encoding Kanr and named JFP143
(ΔnrdI). Both JFP138 (ΔnrdHEKF) and JFP143 (ΔnrdI) failed to grow aerobically;
however, they both grew anaerobically (27).
JFP138 (ΔnrdHEKF) was then complemented with nrdJ, encoding the oxygen
independent class II RNR from L. leichmannii, behind an Isopropyl β-D-1thiogalactopyranoside (IPTG) inducible promoter (27). This mutant was designated
JFP140 (ΔnrdHEKF, nrdJ+) (27). JFP143 (ΔnrdI) was also complemented with nrdJ and
named JFP157 (ΔnrdI, nrdJ+) (27).
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Table 1 Strains used in this study
Strains

Description

S. sanguinis WT isolate from human dental plaque; virulent in rat and rabbit
SK36 models of infective endocarditis
JFP140 Kanr Spcr; ΔnrdHEKF::aphA-3 SSA_0169::aad9 Phyper-spank lacZo
nrdJ lacI
JFP140c Spontaneous mutant of JFP140; Kanr Spcr; ΔnrdHEKF::aphA-3
SSA_0169::aad9 Phyper-spank lacZo nrdJ lacI
1403 JFP140 deleted for nrdI; Kanr Ermr Spcr; ΔnrdHEKF::aphA-3
ΔnrdI::ermB SSA_0169::aad9 Phyper-spank lacZo nrdJ lacI
C3 JFP140c deleted for nrdI; Kanr Ermr Spcr; ΔnrdHEKF::aphA-3
ΔnrdI::ermB SSA_0169::aad9 Phyper-spank lacZo nrdJ lacI
JFP138 Kanr; ΔnrdHEKF::aphA-3
JFP227 JFP173 deleted for SSA_1413; Tetr Kanr; ΔssaACB::tetM
ΔSSA_1413::aphA-3
JFP169 Kanr; ΔssaACB::aphA-3
JFP173 Tetr; ΔssaACB::tetM
JFP157 Kanr Spcr; ΔnrdI::aphA-3 SSA_0169::aad9 Phyper-spank lacZo nrdJ
lacI
JFP163 Cmr Spcr; nrdD::magellan2 SSA_0169::aad9 Phyper-spank lacZo
nrdJ lacI
JFP36 Ermr; SSA_0169::ermB
JFP143 Kanr; ΔnrdI::aphA-3
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Despite the addition of nrdJ, the strains JFP140 (ΔnrdHEKF, nrdJ+) and JFP157
(ΔnrdI, nrdJ+) failed to grow to wild-type, SK36, levels when induced with IPTG. The
strains did, however, grow better than their non-complemented counterparts, JFP138
(ΔnrdHEKF) and JFP143 (ΔnrdI) respectively (27) (Fig 2).
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Figure 2. O2 gradient tube assay with WT and RNR mutants. Tubes were filled with
BHI containing low melting point agarose (LMP) and allowed to become anaerobic, in
an anaerobic chamber. After the tubes become anaerobic they were inoculated and
allowed to solidify in the anaerobic chamber before being transferred to an aerobic
incubator at 37°C. The Resazurin tube contained 5 µg/ml resazurin; the red in the tube
indicated the aerobic region while the clear area is the anaerobic region. The class III
deletion mutant, labeled nrdD, fails to grow anaerobically. All strains with nrdJ were
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grown with 100 µm IPTG and the nrdHEKF nrdJ+ Cbi tube had 320 nm of Cbi, final
concentration, added to the tube. The tubes marked with an orange star are both
JFP140c (SM ΔnrdHEKF, nrdJ+) The tube marked with a blue circle contains JFP140
(ΔnrdHEKF, nrdJ+). Image adapted from Rhodes, D. V., Crump, K. E., Makhlynets, O.,
Snyder, M., Ge, X., Xu, P., Stubbe, J., Kitten, T.
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6. S. sanguinis Native Cobalamin Biosynthesis Pathway
Streptococcus sanguinis has a 70-kb cluster of 68 genes likely acquired by
horizontal gene transfer (HGT; SSA_0463 to SSA_0541) which encodes an anaerobic
cobalamin biosynthesis pathway (cob), a propanediol utilization pathway (pdu) and an
ethanolamine utilization pathway (eut) (30). Enzymes that catabolize 1,2-propanediol
and ethanolamine require coenzyme B12 and these pathways play an important role in
Salmonella species (30). Also S. sanguinis, SK36, has a putative rli55 orthologous with
B12 riboswitches, ANTAR elements and terminator that could regulate ethanolamine
utilization and B12 biosynthesis (31). The fact that SK36 has kept this large 70-kb HGT
region and that nrdJ partially complements a nrdHEKF deletion indicates that cobalamin
(B12) is being synthesized.

7. Spontaneous mutant of JFP140 (ΔnrdHEKF, nrdJ+)
Because nrdJ was not completely complementing the deleted native class Ib
RNR, adenosylcobalamin (coenzyme B12) (AdoCbl) or dicyanocobinamide (Cbi) was
added to cultures to see if the addition would increase growth by potentially providing
AdoCbl for NrdJ or a component of coenzyme B12, Cbi, to stimulate NrdJ function (27).
The addition of AdoCbl to the cultures had no effect at concentrations of 10, 15, 50 and
150 nM. This may be due to the possibility that SK36 does not have an AdoCbl
transporter. The incorporation of Cbi at concentrations of 5 to 80 nM had no effect and
concentrations of 160, 320 and 640 nM inhibited growth (27). However, one culture of
JFP140 (ΔnrdHEKF, nrdJ+) at 320 nM after 48 hours of incubation had an OD660
comparable to wild-type (27). This spontaneous mutant was named JFP140c (SM
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ΔnrdHEKF, nrdJ+) and seemed to have an increase in growth when 320 nM of Cbi was
added to the growth media (27). A tube assay of select RNR mutants is shown in Figure
2.
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J. The Purpose of the Study
The class II gene nrdJ failed to completely complement the native aerobic Mn
dependent RNR due to reasons that are not completely understood. One purpose of
this study was to discover a way to enhance the growth of the nrdJ-complemented
strains and potentially discover the reason why nrdJ is not allowing the mutants to grow
to wild-type levels. Once a mutant without the native aerobic RNR grows to WT levels,
the ssaACB gene can be deleted in this mutant. This new mutant could be tested and if
there is no decrease in virulence then we would know that the aerobic Ib RNR is the
reason for the decrease in virulence when the gene for the Mn transporter, ssaB, is
deleted. However, if there is still a decrease in virulence, then the aerobic Ib RNR is not
the cause for the decrease in virulence with the deletion of ssaB. Another independent
approach to address this question is to compare phenotypes exhibited by the nrdHEKF
mutant when placed under aerobic conditions to that of a manganese-deficient mutant.
If loss of Mn-dependent RNR activity is responsible for loss of aerobic growth in a Mntransporter mutant, then any phenotypes displayed by the RNR mutant should be
shared by the transporter mutant. In contrast, if the RNR mutant and transporter mutant
stop growing for different reasons, then we would expect to see phenotypic differences.
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Research Objective
The Aim of this Study is:
To determine whether manganese-deficient Streptococcus sanguinis cells fail to grow
under aerobic conditions due to reduced activity of the manganese-dependent aerobic
class Ib RNR. Two independent approaches will be used to address this question:
1. Attempt to create a strain that can synthesize deoxynucleotides in the absence of the
native class Ib RNR. This will be accomplished by characterizing existing strains lacking
the class Ib RNR and introducing into them the manganese-independent Class II RNR
from Lactobacillus leichmannii. These experiments will include spontaneous mutants
that grow better aerobically than their parent strains. New strains will also be created. If
this is accomplished as expected, the ssaACB manganese transporter will be deleted to
determine whether manganese depletion reduces virulence to the same extent in a
strain that doesn’t require manganese for deoxynucleotide synthesis.

2. Compare a manganese-deficient strain of S. sanguinis to a strain deleted for the
class Ib RNR to see if the two strains possess similar phenotypes. The microscopic
morphology of the transporter mutant and the nrdHEKF mutant will be compared. In
addition, nucleotide pool analysis will be performed to determine whether the
transporter mutant is depleted for deoxynucleotides.
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II. MATERIALS AND METHODS

A. Broth Preparation: Brain Heart Infusion
Seven and four tenths grams of Bacto™ BHI powder (BD Diagnostic Systems) was
dissolved in 200 mL deionized H2O using a stir bar for mixing on a hot plate. The stir bar
was removed with a magnet and the media was autoclaved for 25 minutes at 121°C.
The Pyrex® glass bottle of media was then covered in aluminum foil and stored at room
temperature. Media was discarded after two weeks to maintain consistent results.

B. Broth Preparation: Chelexed Brain Heart Infusion
Seven and four tenths grams of Bacto™ BHI powder was dissolved in 200 mL
deionized H2O using a stir bar for mixing on a hot plate. Sixteen grams of Chelex per
200 mL was added and allowed to stir for 90 minutes. The stir bar was removed with a
magnet and the media was filter sterilized. One mM calcium and magnesium were
added back to the media. The plastic bottle of media was then covered in aluminum foil
and stored at room temperature. Media was discarded after two weeks to maintain
consistent results.

C. Agar Preparation: Brain Heart Infusion plates
Seven and four tenths grams of Bacto™ BHI powder was dissolved in 200 mL
deionized H2O using a stir bar for mixing on a hot plate. The media was autoclaved for
25 minutes at 121°C. The Pyrex® glass bottle was placed in a 56°C water bath to cool.
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18 mL was poured out into 11 Petri dishes. Plates were poured and allowed to cool and
solidify in a Labconco BSL-2 hood and stored inverted at 4°C.

D. Agar Preparation: Antibiotic Brain Heart Infusion plates
Seven and four tenths grams of BHI powder was dissolved in 200 mL deionized H2O
using a stir bar for mixing on a hot plate. The media was autoclaved for 25 minutes at
121°C. The Pyrex® glass bottle was placed in a 56°C water bath to cool then antibiotics
were added to the media and mixed with the stir bar that remained in the glass jar.
Eighteen mL was poured out into each of 11 Petri dishes. Plates were poured and
allowed to cool and solidify in a Labconco BSL-2 hood and stored inverted at 4°C.

E. Low Melting Point Agar Preparation: Brain Heart Infusion tubes
Eighteen-mL glass tubes with candy cane-shaped aluminum foil tops designed to allow
gas exchange were autoclaved for 25 minutes at 121°C. Three and seven tenths grams
of BHI powder and 1.0 gram of analytical grade LMP agarose (Promega) was dissolved
in 100 mL deionized H2O using a stir bar for mixing on a hot plate. The media was
autoclaved for 25 minutes at 121°C. The Pyrex® glass bottle was placed in a 60°C
water bath to cool. The media was mixed a final time and 10 mL of media was placed in
each of the ten tubes under a Labconco BSL-2 hood. The tubes were quickly filled and
quickly placed in the anaerobic chamber at 37°C. Two days were needed for the tubes
to become completely anaerobic before they were inoculated and allowed to solidify at
room temperature but remained in the anaerobic chamber until solid. Once solid, the
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tubes were taken out of the anaerobic chamber and incubated aerobically at 37°C.
Growth could be seen in 24 to 48 hours.

F. PCR Purification: MinElute® PCR Purification Kit
The QIAGEN© MinElute® PCR Purification Kit, Cat. No. 28004, protocol was followed
except that step 7 used 15 µl of deionized H2O instead of Buffer EB.

G. MinElute® Gel Extraction Kit
The QIAGEN© MinElute® Gel Extraction Kit, Cat. No. 28604, protocol was followed.

H. DNA Extraction: QIAGEN© Streptococcal Genomic DNA Preps
The QIAGEN© DNeasy® Blood and Tissue Kit, Cat. No. 69504, protocol was followed.

I. DNA Extraction: Modified Chromosomal Mini-prep
The modified chromosomal mini-prep protocol was followed, as described in “Genetic
Characterization of a Streptococcus mutans LraI Family Operon and Role in Virulence”
(24).

J. Gene SOEing
Gene SOEing protocol was followed as described in “PCR-mediated recombination and
mutagenesis. SOEing together tailor-made genes” (35).
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K. Streptococcus sanguinis SK36 Transformation Protocol-anaerobic
First a tube of 12.675 ml Bacto™ Todd Hewitt broth (TH) was obtained from the freezer,
prepared as described in Paik et al., 2005 (16). A 1-ml aliquot of horse serum (HS) was
obtained from the freezer and 325 µl was transferred to the tube of TH, creating 13 ml of
TH+HS. Two ml TH+HS were transferred to a BD Falcon™ snap-cap tube and 1 ml to a
microfuge tube. A frozen aliquot was used, JFP140 (ΔnrdHEKF, nrdJ+) or JFP140c (SM
ΔnrdHEKF, nrdJ+), to inoculate the 2 ml tube. Then all the tubes were incubated
overnight at 37°C in the anaerobic chamber. BHI plates were prepared with Kan and
Spc antibiotics added to the media.
The next day, 50 µl of the overnight culture were transferred to 10 ml TH+HS and
returned to the 37°C incubator. Also, the OD600 of the overnight culture was measured
against the 1-ml TH+HS blank. It was around 0.8-0.9. Prior to transformation, around 10
ng of JFP140 (ΔnrdHEKF, nrdJ+) FBA DNA or 10 ng of JFP140c (SM ΔnrdHEKF, nrdJ+)
FBA DNA and 2 ml (70 ng) of competence stimulating peptide (CSP) were placed in
sterile 0.7-ml microfuge tubes and placed in the anaerobic chamber in the 37°C
incubator to pre-warm. The diluted culture was incubated at 37°C for 3 hrs. The OD600
was measured after the 3-hour incubation and it was <0.1. Three hundred and thirty m l
of cell culture was transferred to each microfuge tube with the DNA and CSP and
incubated for 4 hours. After the 4-hour incubation the 2 transformations, JFP140
(ΔnrdHEKF, nrdJ+) transformed using JFP140c (SM ΔnrdHEKF, nrdJ+) FBA DNA and
JFP140c (SM ΔnrdHEKF, nrdJ+) transformed using JFP140 (ΔnrdHEKF, nrdJ+) FBA
DNA, were plated on the BHI plates with kan and spc antibiotics added. Plates were
then placed in an anoxomat jar in 0% O2 and incubated at 37°C for one day.
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L. dNTP extraction for SK36 (WT), JFP227 (ΔssaACB, ΔSSA_1413) and JFP138
(ΔnrdHEKF)
Pre-cultures were made in the anaerobic chamber with 5 ml of anaerobic BHI broth
incubated overnight at 37°C. A frozen aliquot was used, SK36, JFP227 (ΔssaACB,
ΔSSA_1413) and JFP138 (ΔnrdHEKF), to inoculate the pre-culture tubes. Three 19 ml
tubes filled with uninoculated BHI broth, one for each strain, were pre-incubated
anaerobically in the incubator, 37°C. Three baffled flasks with 15 ml of aerobic BHI were
pre-incubated at 37°C aerobically.
The next morning, 1 ml of JFP227 (ΔssaACB, ΔSSA_1413) was added to one tube of
19 ml of BHI (1:20 dilution) and incubated for 3.5 hours anaerobically at 37°C. One and
a half hours after JFP227 (ΔssaACB, ΔSSA_1413) was inoculated, 1 ml of SK36 (WT)
was added to one tube of 19 ml of BHI (1:20 dilution) and incubated for 2 hours
anaerobically at 37°C. At the same time as SK36 (WT), 1 ml of JFP138 (ΔnrdHEKF)
was added to one tube of 19 ml of BHI (1:20 dilution) and incubated for 2 hours
anaerobically at 37°C. After the incubation period, 5 ml of each strain was added to 15
ml BHI in a 250-ml baffled flask (1:4 dilution) and incubated at 37°C in an aerobic
shaker for 2 hours. Each culture, 20 ml, was placed in a 50 ml tube and all 3 tubes
placed in -80°C 100% ethanol (EtOH) until the contents were about to freeze. The tubes
were centrifuged in 4°C at max speed for 10 minutes. The supernatant was poured off
and the pellet was resuspended in 250 µl 70% methanol (MeOH) and transferred to a
screw top microfuge tube. The tubes were placed in a 5°C water bath for three to five
minutes. Tubes were then placed in a 25°C centrifuge and spun for 3 minutes at max
speed. The supernatant was collected and a speedvac was used to dry out the
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contents. The tubes were stored at -80°C and mailed on dry ice to Dr. Kim Baek at
Emory University for analysis of the dNTP levels within the mutants and WT.

26

III. Results

A. Replication of the JFP140c (SM ΔnrdHEKF, nrdJ+) plus Cbi growth study
The first experiment done was the replication of increasing the growth of
JFP140c (SM ΔnrdHEKF, nrdJ+) with the addition of Cbi, as done previously (27).
The pre-culture for JFP140c (SM ΔnrdHEKF, nrdJ+) was grown in 5 ml of BHI
broth with the addition of Kan (500 μg/ml), Spc (200 μg/ml) and 1 mM of IPTG in an
anaerobic chamber at 37°C. After incubating for 16-18 hours the pre-culture was diluted
10-6-fold and inoculated into 5 mL aerobic BHI broth with 1 mM of IPTG plus varying
concentrations of Cbi; 0 nM, 10 nM, 20 nM, 40 nM, 80 nM, 160 nM and 320 nM. These
cultures were incubated at 6% O2 in an Anoxomat Jar at 37°C for 24 hours. These
cultures were then sonicated and plated using a spiral plater on BHI agar. The bacteria
were allowed to grow on the plates anaerobically at 37°C and colonies counted after 24
hours of incubation. There was no effect on growth for concentrations of 10 nM, 20 nM,
and 40 nM Cbi. There was a slight inhibitory effect at 80 nM, a moderate inhibitory effect
at 160 nM and no growth at 320 nM (Fig. 3). In summary, there was no increase in
growth at any concentration with the addition of Cbi and only an inhibitory effect at the
higher concentrations.
Cbi was added to JFP140c (SM ΔnrdHEKF, nrdJ+) multiple times except cultures
were assayed for OD660 (Table 2) instead of being plated. Consistently, JFP140c (SM
ΔnrdHEKF, nrdJ+) grew at concentrations of 40 nM and below very similarly to 0 nM of
Cbi. However, there was a slight (0.010 to 0.030 OD units) increase in OD660 around
concentrations of 20 to 40 nM Cbi in most cases.
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Figure 3. Effect of addition of Cbi on the growth of JFP140c (SM ΔnrdHEKF,
nrdJ+). The x-axis is the Cbi concentration and the y-axis is the cfu/ml on a log scale.
The 320 nM Cbi concentration was at the limit of detection (indicated by the dashed
line).
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Table 2 OD660 Readings of JFP140c (SM ΔnrdHEKF, nrdJ+) with the addition of Cbi
Cbi conc.

OD660

(nM)

Expt. 1

Expt. 2

Expt. 3

Expt. 4

0

0.082

0.426

0.086

0.167

10

0.096

0.498

15
20

0.180
0.103

0.315

0.121

25

0.199
0.157

30

0.112

40

0.119

80

0.065

160

0.004

320

0.000

0.266

*Expt. 1 & 3 – 21 hours, Expt. 2 – 24 hours, Expt. 4 – 22 hours
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JFP140c (SM ΔnrdHEKF, nrdJ+) failed to show an increase in growth when Cbi
was added and Cbi actually had an inhibitory effect at higher concentrations. The failure
to replicate the previous stimulation of growth could be due to Cbi being left out in room
temperature when the experiment was performed previously. Being left at room
temperature, the Cbi may have broken down into components that helped growth of
JFP140c (SM ΔnrdHEKF, nrdJ+).

B. The Addition of Dimethylbenzimidazole (DMB)
It has been reported that Salmonella enterica can produce B12 from Cbi only if
DMB is also provided (32). Because of the slight increase in growth at 20 nM and 40
nM, 20 nM was used as the standard Cbi concentration while testing DMB
concentrations. DMB was dissolved in 95% - 100% Ethanol (EtOH). To make sure that
the EtOH was not affecting growth, a vehicle of 5 µL 95% - 100% EtOH was added to a
control culture with no Cbi or DMB added. Five µL was chosen because no addition of
DMB would exceed 5 µL. Concentrations were as follows: 0 nM Cbi, 0 nM DMB
(control); 0 nM Cbi, 5 µL 95% - 100% EtOH (vehicle control); 20 nM Cbi, 0 nM DMB; 20
nM Cbi, 0.32 µM DMB; 20 nM Cbi, 150 µM DMB; 20 nM Cbi, 300 µM DMB (Table 3). All
cultures and concentrations had 1 mM of IPTG added. DMB persistently inhibited
growth of JFP140c (SM ΔnrdHEKF, nrdJ+) with increasing concentration. EtOH had no
effect on growth of the cultures and was not a factor.
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Table 3 OD660 Readings of JFP140c (SM ΔnrdHEKF, nrdJ+) with the addition of Cbi
and DMB
Cbi conc. & DMB conc.
(nM)

(µM)

OD660
Expt. 1

Expt. 2

Expt. 3

0 nM Cbi + 0 µM DMB

0.178

0.204

0 nM Cbi + 5 µL 100% EtOH*

0.183

0.221

20 nM Cbi + 0 µM DMB

0.181

20 nM Cbi + 0.32 µM DMB

0.169

20 nM Cbi + 150 µM DMB

0.114

0.259

0.131

20 nM Cbi + 300 µM DMB

0.072

0.160

0.092

*Vehicle control
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0.286

0.189
0.142

C. Addition of Ethanolamine
Another potential way to stimulate B12 production in the nrdJ+ mutants was to add
ethanolamine. B12 is needed to breakdown ethanolamine, and S. sanguinis has an
ethanolamine utilization gene (eut) in close proximity to the B12 biosynthetic pathway
(cob). The addition of ethanolamine to the wild-type strain appeared to cause an
increase in growth. At concentrations of 5 mM, 10 mM, 15 mM, 20 mM, 25 mM and 30
mM there was a definite increase in growth and a slight trend upward with the addition
of higher concentrations of ethanolamine (Fig 4). This would suggest that the 70kb HGT
region is producing coenzyme B12 and that eut is working to some extent. A similar
upward trend was also seen with JFP157 (ΔnrdI, nrdJ+) when ethanolamine was added
to the growth media. However, with JFP140 (ΔnrdHEKF, nrdJ+) there was no increase
in growth with ethanolamine. It should be noted that JFP157’s (ΔnrdI, nrdJ+) growth rate
was much higher than JFP140 (ΔnrdHEKF, nrdJ+) in oxygenated environments. This
would seem to be contradictory with the previous tube assay (Fig 2). It is currently
unknown why JFP157 (ΔnrdI, nrdJ+) has a better growth rate than JFP140 (ΔnrdHEKF,
nrdJ+) in oxygenated BHI. JFP140c (SM ΔnrdHEKF, nrdJ+) has a varied pattern of
growth. At low OD600 there was no increase in growth upon addition of ethanolamine.
However, at higher OD600 readings above 0.5, there was an increase in growth at low
levels of ethanolamine 5 mM to 15 mM. Beyond 15 mM there was an inhibitory effect on
the growth of JFP140c (SM ΔnrdHEKF, nrdJ+).
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Ethanolamine (mM)
1.4

1.2

1

0.8

0.6

0.4

0.2

0
0 mM

5 mM

10 mM
SK36
JFP140

15 mM
JFP140c

20 mM
1403
C3

25 mM
JFP157

30 mM

Figure 4. Addition of Ethanolamine to strains SK36 (WT), JFP140 (ΔnrdHEKF,
nrdJ+), JFP140c (SM ΔnrdHEKF, nrdJ+), JFP157 (ΔnrdI, nrdJ+) and C3 (SM
ΔnrdHEKF, ΔnrdI, nrdJ+), and 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+). The x-axis is the
ethanolamine concentration in mM and the y-axis is the OD600 readings.
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D. Gene SOEing to create ΔnrdHEKF, ΔnrdI, nrdJ+
When JFP157 (ΔnrdI, nrdJ+) was tested with ethanolamine, it grew better than
JFP140 (ΔnrdHEKF, nrdJ+), not just with the addition of ethanolamine but also without
ethanolamine. The deletion of the gene nrdI from JFP140 (ΔnrdHEKF, nrdJ+) might
have changed the growth pattern to be more like that of JFP157 (ΔnrdI, nrdJ+) or stayed
similar to its parent JFP140 (ΔnrdHEKF, nrdJ+). The deletion of the gene nrdI from
JFP140c (SM ΔnrdHEKF, nrdJ+), if the deletion did increase growth, could boost
JFP140c (SM ΔnrdHEKF, nrdJ+) to WT levels. Using the gene SOEing technique,
described in the materials and methods section, JFP140 (ΔnrdHEKF, nrdJ+) and
JFP140c (SM ΔnrdHEKF, nrdJ+) had nrdI deleted and replaced with an erythromycin
resistance cassette (Ermr) (Fig 5). The double deletion mutant for JFP140 (ΔnrdHEKF,
nrdJ+) was named 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) and the double deletion mutant for
JFP140c (SM ΔnrdHEKF, nrdJ+) was named C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+) (Fig 6).
This was done to see if the growth patterns would mimic JFP140 (ΔnrdHEKF, nrdJ+) or
JFP157 (ΔnrdI, nrdJ+) using a tube assay to assess the growth pattern (Fig 6).
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2901

Figure 5. Gene SOEing diagram and primers for the creation of strains 1403
(ΔnrdHEKF, ΔnrdI, nrdJ+) and C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+). Primers A-J are
indicated on the diagram with where the primers start. The Erm promoter region is
indicated with the black closed arrows.
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C3
SM
ΔnrdHEKF,
ΔnrdI, nrdJ+

1403
ΔnrdHEKF,
ΔnrdI, nrdJ+

SK36
WT

Figure 6. O2 gradient tube assay using 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) and C3 (SM
ΔnrdHEKF, ΔnrdI, nrdJ+). The tube assay for C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+) and
1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) were done at the same time. SK36 (WT) was taken from
Fig 2.
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The strain 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) grows similarly to JFP140 (ΔnrdHEKF,
nrdJ+), in that it does not grow in the aerobic region. However, C3 (SM ΔnrdHEKF,
ΔnrdI, nrdJ+) grows much better than JFP140c (SM ΔnrdHEKF, nrdJ+) in the tube
assay. C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+) seems to grow almost to WT levels.

E. Ethanolamine effect on 1403 and C3
Strains 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) and C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+)
were tested with ethanolamine to see how they compared to either JFP157 (ΔnrdI,
nrdJ+) or JFP140 (ΔnrdHEKF, nrdJ+) and JFP140c (SM ΔnrdHEKF, nrdJ+). (Fig 4) The
strain 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) appeared similar to JFP140 (ΔnrdHEKF, nrdJ+) in
both the standard growth study using BHI and also with the LMP tube assay. C3 (SM
ΔnrdHEKF, ΔnrdI, nrdJ+) grew to what seemed to be wild-type levels using the tube
assay but the growth pattern in BHI broth was similar to JFP140c (SM ΔnrdHEKF,
nrdJ+). When ethanolamine was added to the media the new mutants 1403 (ΔnrdHEKF,
ΔnrdI, nrdJ+) and C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+) grew similarly to their parent strains.
Growth of 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+) was not affected when ethanolamine was
used and C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+) showed a slight increase in growth at low
levels 5 mM and 10 mM of ethanolamine and less growth at the higher levels, above 10
mM. Again, this rise and fall in growth was only at higher OD600 readings while at lower
readings, ethanolamine had no effect on the growth pattern.
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F. Addition of 1,2-propanediol
Propanediol utilization genes (pdu) are also on the 70kb region with the B12
biosynthetic pathway (cob) along with the ethanolamine utilization genes (eut). The
addition of 1,2-propanediol could have resulted in a better growth increase than
ethanolamine. However, 1,2-propanediol had no growth effect on the strains. There was
no increase in growth even for the WT, SK36. JFP140 (ΔnrdHEKF, nrdJ+), JFP140c
(SM ΔnrdHEKF, nrdJ+), 1403 (ΔnrdHEKF, ΔnrdI, nrdJ+), C3 (SM ΔnrdHEKF, ΔnrdI,
nrdJ+) and JFP157 (ΔnrdI, nrdJ+) did not have an increase in growth and no inhibitory
effects were observed with 1,2-propanediol (Fig 7).
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1,2-Propandiol (mM)
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JFP140c
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Figure 7. Addition of 1,2-propanediol to strains SK36 (WT), JFP140c (SM
ΔnrdHEKF, nrdJ+), JFP157 (ΔnrdI, nrdJ+) and C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+).
The x-axis is the 1,2-propaindiol concentration in mM and the y-axis is the OD600
readings.
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G. Characterization of Spontaneous Mutants
The addition of Cbi, DMB, ethanolamine and 1,2-propanediol all failed to
stimulate growth of the strains tested to WT levels. However, JFP140c (SM ΔnrdHEKF,
nrdJ+) showed increased growth in the presence of oxygen compared to its parent
JFP140 (ΔnrdHEKF, nrdJ+). This spontaneous suppressor mutant, containing a
naturally occurring second mutation that reverts the phenotype of the first mutation, that
may have been selected for by the addition of Cbi were hypothesized to have a
secondary mutation that increases expression of the nrdJ gene or that increased
production of coenzyme B12. However, those ideas were just early speculations.
Another hypothesis of why JFP140c (SM ΔnrdHEKF, nrdJ+) grew better was
because it was producing mini-cells without DNA. When extracting DNA from JFP140c
(SM ΔnrdHEKF, nrdJ+) and JFP140 (ΔnrdHEKF, nrdJ+), more DNA was extracted from
JFP140 (ΔnrdHEKF, nrdJ+) even though JFP140c (SM ΔnrdHEKF, nrdJ+) grew to
higher OD levels. JFP140c (SM ΔnrdHEKF, nrdJ+) was hypothesized to be making minicells without DNA, which might have a higher OD600. 4',6-diamidino-2-phenylindole
(DAPI) staining was performed to see if this was true. The DAPI staining clearly
indicates that JFP140c (SM ΔnrdHEKF, nrdJ+) does not have mini-cells. All JFP140c
(SM ΔnrdHEKF, nrdJ+) cells have DNA within them (Fig 8).
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Figure 8. DAPI staining of JFP140c (SM ΔnrdHEKF, nrdJ+) and SK36 (WT). Preculture cells were grown anaerobically. Overnight cultures, which were inoculated with a
10-6 dilution of the pre-culture, were grown in 6% O2. DAPI (1:10,000) was added for 60
minutes and washed with PBS. Cells were viewed at 100x magnification with a Zeiss
AxioObserver fluorescent microscope with an excitation wavelength of 365 nm and an
emission of 445.
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The creation of additional suppressor mutants (SM) that grow better than their
parents, such as in the case of JFP140 (ΔnrdHEKF, nrdJ+) and JFP140c (SM
ΔnrdHEKF, nrdJ+), could be beneficial. A collection of suppressor mutants with different
mutations could be combined to create a strain that grows to WT levels without
nrdHEKF and/or nrdI but with nrdJ. An LMP tube assay was used to identify other
spontaneous suppressor mutants. As seen in Figure 2, some strains that were
ΔnrdHEKF, nrdJ+ or ΔnrdI, nrdJ+ had growth in the aerobic portion of the tube. These
colonies in the aerobic zone were hypothesized to be suppressor mutants.
Due to the favorable growth of JFP157 (ΔnrdI, nrdJ+), tube assays were made to
collect colonies in the aerobic portion and to grow these colonies in LMP tubes and
compare the parent from the potential suppressor mutant. Six potential suppressor
mutants were created and stored for whole genome sequencing (Fig 9). All, the SM
ΔnrdI, nrdJ+ were growing to near WT levels. There is however a “line” with limited
growth at the boundary of the aerobic and anaerobic region.
To try to find other mutants, JFP163 (ΔnrdD, nrdJ+), which is deleted for the
anaerobic RNR rather than the aerobic RNR, was tested to find suppressor mutants
using tube assays also. Nine potential suppressor mutants were collected and stored for
whole genome sequencing (Fig 10).
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Figure 9. O2 gradient tube assay using JFP157 (ΔnrdI, nrdJ+) and a potential SM of
JFP157 (SM ΔnrdI, nrdJ+). SK36 (WT) was used as a reference and taken from Fig 2.
The potential SM of JFP157 (SM ΔnrdI, nrdJ+) is in the middle. While JFP157 (ΔnrdI,
nrdJ+) is on the left. All of the six SM JFP157 grew similarly to the middle photo.
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Figure 10. O2 gradient tube assay using JFP163 (ΔnrdD, nrdJ+) and SM JFP163 1.1
(SM ΔnrdD, nrdJ+). SK36 (WT) was used as a reference and taken from Fig 2. The
SM of JFP163 (SM ΔnrdD, nrdJ+) is in the middle. While JFP163 (ΔnrdD, nrdJ+) is on
the left.
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H. Whole-Genome Sequencing
After some potential spontaneous mutants, which grew better than their parent
strains, were isolated, whole genome sequencing was performed to identify potential
mutations within these strains. However, to make sure that the nucleotide changes
observed, if any, were truly novel the parent strains were also sequenced including
SK36 (WT) (Table 4). We wanted to understand why JFP140c (SM ΔnrdHEKF, nrdJ+)
grows better than its parent JFP140 (ΔnrdHEKF, nrdJ+). Strains were sent off for
sequencing. SK36 (WT) was re-sequenced to confirm its sequence and to potentially
see any changes in the genome since sequencing it in 2007. JFP138 (ΔnrdHEKF) was
sequenced because it was the parent of JFP140 (ΔnrdHEKF, nrdJ+). JFP143 (nrdI) was
sequenced because it was the parent of JFP157 (ΔnrdI, nrdJ+).
The sequencing and analysis were done by VCU Nucleic Acid Research
Facilities - Genomics Core. Strains SK36 (WT), JFP140 (ΔnrdHEKF, nrdJ+), JFP140c
(SM ΔnrdHEKF, nrdJ+), JFP138 (ΔnrdHEKF) were sequenced by Illumina sequencing,
Paired End Read, 2 x 300 bp MiSeq. To confirm our sequencing results, the prior
strains were sequenced again and the new spontaneous suppressor mutants were also
sequenced. They were also sequenced by Illumina sequencing, MiSeq, Paired End
Read, 2 x 300 bp. However, analysis of the sequences was done with Geneious, a
bioinformatic software program, within our lab.
There were no mutations found in any of the potential SM JFP157 (SM ΔnrdI,
nrdJ+) when compared with the parent strain, JFP157 (ΔnrdI, nrdJ+). This failure to
detect a mutation within SM JFP157 (SM ΔnrdI, nrdJ+) might be because the mutation,
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if any, was in a region of the genome that contained repeats. One example would be in
the tRNA and rRNA regions of the genome. In the potential suppressor mutants of
JFP163 (ΔnrdD, nrdJ+), only one strain contained mutations. SM JFP163 1.1 (SM
ΔnrdD, nrdJ+) had a single nucleotide polymorphism (SNP) in the nox gene, which was
confirmed by Sanger sequencing (Fig 11). The nox gene encodes an NADH oxidase
that can replenish NAD+ consumed during glycolysis at the expense of oxygen (35, 36).
Also, JFP163 1.1 (SM ΔnrdD, nrdJ+) had an SNP in gene SSA_1239, which encodes a
putative membrane protein (Fig 12). Finally, the only difference found in JFP140c (SM
ΔnrdHEKF, nrdJ+) compared to JFP140 (ΔnrdHEKF, nrdJ+) was a single SNP in the
fructose bisphosphate aldolase (fba) gene (Fig 13). This SNP was seen in two
independent whole genome sequencing experiments.
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Table 4 Strains that were whole genome sequenced with Illumina sequencing

Whole genome sequencing

Description

Strains
SK36

Wild-Type (Streptococcus sanguinis)

JFP138

ΔnrdHEKF

JFP143

ΔnrdI

JFP140

ΔnrdHEKF, nrdJ+

JFP140c
C3
JFP157

SM ΔnrdHEKF, nrdJ+
SM ΔnrdHEKF, ΔnrdI, nrdJ+
ΔnrdI, nrdJ+

JFP157 SM 1

Potential SM ΔnrdI, nrdJ+ #1

JFP157 SM 2

Potential SM ΔnrdI, nrdJ+ #2

JFP157 SM 3

Potential SM ΔnrdI, nrdJ+ #3

JFP157 SM 4

Potential SM ΔnrdI, nrdJ+ #4

JFP157 SM 5

Potential SM ΔnrdI, nrdJ+ #5

JFP157 SM 6

Potential SM ΔnrdI, nrdJ+ #6

JFP157 SM 7

Potential SM ΔnrdI, nrdJ+ #7

JFP163 clone 1

Clone 1 ΔnrdD, nrdJ+

JFP163 1.1

Clone 1 Potential SM ΔnrdD, nrdJ+ #1

JFP163 1.2

Clone 1 Potential SM ΔnrdD, nrdJ+ #2

JFP163 1.3

Clone 1 Potential SM ΔnrdD, nrdJ+ #3

JFP163 1.4

Clone 1 Potential SM ΔnrdD, nrdJ+ #4

JFP163 1.5

Clone 1 Potential SM ΔnrdD, nrdJ+ #5
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JFP163 clone 2

Clone 2 ΔnrdD, nrdJ+

JFP163 2.1

Clone 2 Potential SM ΔnrdD, nrdJ+ #1

JFP163 2.2

Clone 2 Potential SM ΔnrdD, nrdJ+ #2

JFP163 2.3

Clone 2 Potential SM ΔnrdD, nrdJ+ #3

JFP163 2.4

Clone 2 Potential SM ΔnrdD, nrdJ+ #4
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Figure 11. Geneious software image of the SNP in the nox gene for JFP169 1.1
(SM ΔnrdD, nrdJ+). The SNP within nox had an adenine replaced with a cytosine,
highlighted with a red box. This changed the amino acid from a glutamine to a histidine.
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Figure 12. Geneious software image of the SNP in SSA_1239 for JFP169 1.1 (SM
ΔnrdD, nrdJ+). The SNP within SSA_1239 had a cytosine replaced with a guanine,
highlighted with a red box. This changed the amino acid from a tryptophan to a cysteine.
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Figure 13. Geneious software image of the SNP in Fba for JFP140c (SM
ΔnrdHEKF, ΔnrdI, nrdJ+). The SNP within Fba had a guanine replaced with a thymine,
highlighted with a red box. This changed the amino acid from a threonine to an
asparagine.
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I. Transformation of JFP140 (ΔnrdHEKF, nrdJ+) with JFP140c (SM ΔnrdHEKF,
nrdJ+) fba and JFP140c (SM ΔnrdHEKF, nrdJ+) with JFP140 (ΔnrdHEKF, nrdJ+) fba
The SNP in JFP140c’s (SM ΔnrdHEKF, nrdJ+) fba gene was independently
confirmed with whole genome sequencing to be the only mutational difference from
JFP140 (ΔnrdHEKF, nrdJ+). To make sure this mutation truly caused the growth
difference between JFP140 (ΔnrdHEKF, nrdJ+) and JFP140c (SM ΔnrdHEKF, nrdJ+), a
transformation was performed to put JFP140’s (ΔnrdHEKF, nrdJ+) fba into JFP140c
(SM ΔnrdHEKF, nrdJ+) and JFP140c’s fba into JFP140. Transformation was performed
by the protocol described in the Materials and Methods section. Note that antibiotic
selection was not used, so it was expected that the majority of colonies would not have
taken up the DNA. Twenty-three colonies were picked for JFP140 (ΔnrdHEKF, nrdJ+)
transformed with the fba variant from JFP140c (SM ΔnrdHEKF, nrdJ+) and grown in
both 0% and 6% oxygenated BHI alongside controls of untransformed JFP140
(ΔnrdHEKF, nrdJ+) and JFP140c (SM ΔnrdHEKF, nrdJ+) in both 0% and 6% oxygen.
Out of the twenty-three colonies picked, only seven grew to JFP140c (SM ΔnrdHEKF,
nrdJ+) like levels. After sequencing the fba region with the SNP, only one sample
contained the sequence of the JFP140c (SM ΔnrdHEKF, nrdJ+) fba gene.
Twenty-three samples were picked for JFP140c (SM ΔnrdHEKF, nrdJ+)
transformed with the fba gene from JFP140 (ΔnrdHEKF, nrdJ+) and grown in both 0%
and 6% oxygenated BHI with a control of JFP140 (ΔnrdHEKF, nrdJ+) and JFP140c (SM
ΔnrdHEKF, nrdJ+) in both 0% and 6% oxygen also. Out of the twenty-three samples
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only five seemed to grow like JFP140 (ΔnrdHEKF, nrdJ+). After sequencing the fba
region with the SNP, only one sample contained the JFP140 (ΔnrdHEKF, nrdJ+) allele.
When the two transformed samples were grown with JFP140 (ΔnrdHEKF, nrdJ+)
and JFP140c (SM ΔnrdHEKF, nrdJ+) for controls and with two failed transformants from
JFP140c (SM ΔnrdHEKF, nrdJ+) transformed with JFP140 (ΔnrdHEKF, nrdJ+) fba and
two from JFP140 (ΔnrdHEKF, nrdJ+) transformed with JFP140c (SM ΔnrdHEKF, nrdJ+)
fba, the successful transformants had the same phenotype and growth pattern as the
strain that was the source of the fba region (Fig 14). The mutation in the fba gene is
therefore causal to the improved-growth phenotype of the JFP140c (SM ΔnrdHEKF,
nrdJ+) suppressor mutant.
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[A]

[B]

[C]

[D]

[E]

[F]

Strain:

JFP140c

JFP140c

JFP140

JFP140

JFP140

JFP140c

Fba:

JFP140c

JFP140c

JFP140

JFP140

JFP140c

JFP140

Figure 14. Transformation of JFP140 (ΔnrdHEKF, nrdJ+) with JFP140c fba and
JFP140c (SM ΔnrdHEKF, nrdJ+) with JFP140 fba. [A] is a failed transformation of
JFP140c with JFP140 fba, numbered #21 (out of 23). [B] is a failed transformation of
JFP140c with JFP140 fba, numbered #5 (out of 23). [C] is a failed transformation of
JFP140 with JFP140c fba, numbered #13 (out of 23). [D] is a failed transformation of
JFP140 with JFP140c fba, numbered #17 (out of 23). [E] is a successful transformation
of JFP140 with JFP140c fba, numbered #3 (out of 23). [F] is a successful transformation
of JFP140c with JFP140 fba, numbered #3 (out of 23).
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J. Protein Structure of the Fba region in JFP140 (ΔnrdHEKF, nrdJ+) and JFP140c
(SM ΔnrdHEKF, nrdJ+)
The mutation within JFP140c’s (SM ΔnrdHEKF, nrdJ+) fba gene caused an
amino acid change. To understand how the amino acid change affects the overall
protein SWISS-MODEL (https://swissmodel.expasy.org/) was used to visualize the
protein and its alignment to Staphylococcus aureus’s FBA (Fig 15 & Fig 16). The SNP
changes a threonine into an asparagine. Both amino acids are polar with uncharged
side chains but clearly this change causes the growth difference seen in JFP140
(ΔnrdHEKF, nrdJ+) and JFP140c (SM ΔnrdHEKF, nrdJ+). The SNP in JFP140c (SM
ΔnrdHEKF, nrdJ+) was in an active site of FBA when compared to the S. aureus model
(33).
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Figure 15. SWISS-MODEL used to make an alignment with JFP140 (ΔnrdHEKF,
nrdJ+) and Methicillin-Resistant Staphylococcus aureus (4to8.1.A). The yellow
boxes indicate the active sites of S. aureus’s Fba and the alignment to the Fba in
JFP140 (ΔnrdHEKF, nrdJ+). The yellow triangles indicate the amino acid that was
changed in JFP140c (SM ΔnrdHEKF, nrdJ+). Image was taken from SWISS-MODEL
(https://swissmodel.expasy.org/interactive/ue5PYL/models/)
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Figure 16. SWISS-MODEL used to make an alignment with JFP140c (SM
ΔnrdHEKF, nrdJ+) and Methicillin-Resistant Staphylococcus aureus (4to8.1.A).
The black boxes indicate the active sites of S. aureus’s Fba and the alignment to the
Fba in JFP140c (SM ΔnrdHEKF, nrdJ+). The black triangles indicate the amino acid that
was changed in JFP140c (SM ΔnrdHEKF, nrdJ+). Image was taken from SWISSMODEL (https://swissmodel.expasy.org/interactive/rqmU8B/models/)
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K. Phenotypic comparison of SK36 (WT), JFP227 (ΔssaACB, ΔSSA_1413) and
JFP138 (ΔnrdHEKF)
If reduced activity of the manganese-dependent aerobic RNR is the reason why
the ΔssaACB mutant has reduced virulence, there might be phenotypic changes that
are shared by both a manganese uptake mutant and the nrdHEKF mutant, JFP138
(ΔnrdHEKF). JFP227 (ΔssaACB, ΔSSA_1413) was used rather than JFP169
(ΔssaACB) because JFP227 (ΔssaACB, ΔSSA_1413) has another apparent Mn
transporter deleted, SSA_1413, in addition to ΔssaACB, and is therefore more severely
depleted for manganese. It was necessary to use this strain because although ssaB and
ssaACB mutants grow poorly in low-Mn media when inoculated at low cell densities,
their growth improves markedly when inoculated at the higher cell densities that are
required for the biochemical analyses we had planned. (See below.)
SK36 (WT), JFP227 (ΔssaACB, ΔSSA_1413) and JFP138 (ΔnrdHEKF) were all
grown in BHI and stressed with oxygen using shaking baffled flasks. Under a light
microscope at 100x, pictures were taken of the cells at time 0 minutes, 30 minutes, 120
minutes and 180 minutes. There is a phenotypic change with the introduction of oxygen
causing an elongation of the cells of JFP227 (ΔssaACB, ΔSSA_1413) and JFP138
(ΔnrdHEKF) (Fig 17).
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Figure 17. Phenotypic changes caused by oxygen stress over time on SK36 (WT),
JFP227 (ΔssaACB, ΔSSA_1413) and JFP138 (ΔnrdHEKF). Strains were transferred
out of the anaerobic chamber into an aerobic shaker at 37°C. Time points are 0
minutes, viewed right after the cultures left the anaerobic chamber, 30 minutes, 120
minutes and 180 minutes, after strains were put in the shaker. Phase-contrast
microscope was used at 100x.
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L. Deoxynucleotide analysis of SK36 (WT), JFP138 (ΔnrdHEKF) and JFP227
(ΔssaACB, ΔSSA_1413)
Another test to see if the decrease in virulence from the lack of Mn was because
of a deficiency in RNR, was to analyze the dNTP content of the strains. Strains were
lysed prior to oxygen stress and two hours after oxygen stress to check dNTP levels.
Analysis was done by Dr. Kim Baek’s lab at Emory University.
Data are currently being generated.
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IV. Discussion

This study had two goals. The first goal had two different approaches. The first
goal was to create a mutant or create an environment in which the deleted class Ib RNR
could be complemented with the class II RNR from L. leichmannii. The class II RNR
was used because class Ia failed to work in the ∆nrdHEKF mutant (27). One way to do
this would be to stimulate the native B12 biosynthetic pathway to produce more B12 for
the nrdJ-containing mutants or by the addition of components of B12, Cbi and DMB, to
help alleviate the energy burden of creating B12. The second way was to create a
suppressor mutant that can grow to WT levels without the native aerobic RNR and with
the class II RNR, NrdJ. The second goal was to compare the phenotypic characteristics
and deoxyribonucleotide amounts of a Mn transporter mutant and the class Ib mutant
(ΔnrdHEKF).
S. sanguinis fails to grow aerobically with the deletion of the aerobic class Ib
RNR. Ectopically expressing nrdJ in place of the missing RNR fails to completely
complement activity of the native RNR. S. sanguinis has a 70kb-HGT region with a B12
biosynthetic pathway and should produce coenzyme B12, on the assumption that the
bacteria would not have maintained such a large HGT region with no explanation. One
thought of why nrdJ is not fully complementing is that the B12 pathway is not producing
enough B12 or that the pathway is not being stimulated enough to work with the class II
RNR. The addition of B12 to the media might have helped with the stimulation of NrdJ
activity; however, it is unknown if S. sanguinis has a B12 transporter since none have
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been found to date. The addition of B12 components into the media, such as Cbi or
DMB, failed to produce a positive growth response.
Addition of ethanolamine and 1,2-propanediol was used to stimulate B12
production in S. sanguinis since the genes to utilize these two compounds are found on
the same 70kb-HGT region. The addition of 1,2-propanediol failed to create a response
in the strains tested, even WT. However, ethanolamine seemed to increase the growth
of strains SK36 (WT), JFP40c (SM ΔnrdHEKF, nrdJ+) and JFP157 (ΔnrdI, nrdJ+) at
higher OD600 (> 0.5) readings. At the lower concentrations of ethanolamine, the growth
seemed to be stimulated, but at higher levels the growth was inhibited. It is possible that
at lower levels of ethanolamine, the B12 biosynthetic pathway is stimulated to produce
more B12. The extra B12 then is used by NrdJ to create more dNTPs and increases the
growth of the strain. However, at higher concentrations, B12 is consumed in the
degradation of ethanolamine and B12 is shunted away from NrdJ creating an inhibitory
effect. Also, the biosynthetic pathways could have a limit to the amount of B12 produced
and only at low concentrations is the B12 pathway stimulated with only a minimal amount
of it going to the breakdown of ethanolamine. However, because SK36 (WT) showed an
increase in growth and since SK36 (WT) has no need for B12 to drive NrdJ activity, the
increase in growth for all the strains must be due to the breakdown products of
ethanolamine. Ethanolamine must be providing a carbon or nitrogen source that is
increasing growth. B12 is most likely not being shunted to NrdJ.
Potentially, the growth deficiency of the nrdJ-containing strain could nevertheless
be from the lack of sufficient B12. The insertion of a B12 transporter from Bacillus subtilis
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or Enterococcus faecalis could reveal if the lack of B12 is definitively the cause of the
nrdJ mutants’ failure to grow to WT levels. This could be a future experiment.
Cbi had an inhibitory effect at high concentrations while DMB had no effect on
growth; even when used in combination, both failed to produce an increase in growth.
The strain JFP140c (SM ΔnrdHEKF, nrdJ+), which was thought to be able to use Cbi to
increase growth, was found to be a suppressor mutant with a single SNP in the Fba
protein that changes an amino acid in the active site, as seen in S. aureus (33).
Sequencing has revealed that a single SNP is the only apparent difference
between JFP140 (ΔnrdHEKF, nrdJ+) and JFP140c (SM ΔnrdHEKF, nrdJ+). By
transforming the region with the mutation, the WT into the mutant and vice versa, it
affirmed that the change of the nucleotide was the reason for the growth differences.
Also, because C3 (SM ΔnrdHEKF, ΔnrdI, nrdJ+) grows similarly to JFP140c (SM
ΔnrdHEKF, nrdJ+) in broth cultures yet better in the tube assay, C3 (SM ΔnrdHEKF,
ΔnrdI, nrdJ+) could be a better choice to evolve into a strain that grows to WT levels
without a Mn-dependent RNR. Fba is a protein that uses Zn and its increase in growth
should not be connected to Mn. Fba is an enzyme catalyzing a reversible reaction that
splits, fructose 1,6-bisphosphate, into the triose phosphates dihydroxyacetone
phosphate (DHAP) and glyceraldehyde 3-phosphate (G3P). The fact that the growth of
JFP140c (SM ΔnrdHEKF, nrdJ+) was improved by mutation of the fba gene rather than
of a gene or regulator of the B12 biosynthetic region may indicate that the failure of the
nrdJ-containing strain to grow as well as a nrdHEKF-containing strain is not due to
inadequate levels of cellular B12. Further studies will be required to determine why the
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mutation of the fba gene improves aerobic growth of the nrdJ-complemented nrdHEKF
mutant (JFP140c).
We know Fba is the reason that JFP140c (SM ΔnrdHEKF, nrdJ+) has a better
growth rate than JFP140 (ΔnrdHEKF, nrdJ+) and we can form a new hypothesis on why
JFP140c (SM ΔnrdHEKF, nrdJ+) had a high OD reading but a low DNA yield. The
products of Fba feed into cell wall synthesis (38). Alteration of Fba’s activity might
therefore conceivably thicken the peptidoglycan layer, making the cells harder to lyse,
which would explain the lower DNA yield obtained from the Fba suppressor mutant. It is
not yet clear why this change would improve the aerobic growth of the suppressor
mutant. Alternatively, Fba has been classified as a “moonlighting protein”, meaning that
it has functions unrelated to glycolysis (37). Thus, it’s possible that the mutation
improves growth and/or reduces DNA yield by modifying an unknown function of Fba.
The phenotypic changes seen in JFP138 (ΔnrdHEKF) and JFP227 (ΔssaACB,
ΔSSA_1413) were similar. Both strains had exaggerated elongation of cells at longer
time points after oxygen stress (>2 hours). This could be morphological evidence that
the shortage of Mn that prevents growth of uptake mutants in Mn-limited environments
also reduces the activity of the aerobic Mn dependent RNR. This failure allows for the
cells to elongate but fail to divide from the lack of dNTPs to replicate and/or repair DNA.
The analysis of the dNTPs from the lysates of SK36 (WT), JFP138 (ΔnrdHEKF)
and JFP227 (ΔssaACB, ΔSSA_1413) should reveal a better understanding of whether
lack of dNTPs because of deletion of nrdHEKF is the reason why the decrease in Mn
causes S. sanguinis to lose its virulence.
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Deletion of ssaACB, a Mn transporter, decreased virulence of S. sanguinis. Mn is
somehow important to aerobic virulence. SodA, within S. sanguinis, is a superoxide
dismutase that uses Mn. SodA seemed like an obvious reason why the cell would need
Mn in oxygen; however, the deletion of SodA did reduce virulence but not to the same
extent as the deletion of ssaACB (25). This means that Mn is used for something within
S. sanguinis that is more critical than superoxide dismutase.
A crucial system that uses Mn in S. sanguinis is the native class Ib RNR. The
deletion of RNR causes a massive loss in virulence in S. sanguinis. In the animal
studies, the ΔnrdHEKF mutant could not be recovered from the animal after 20 hours.
Even the DNA was unrecoverable (27). This makes this mutant the most incapacitated
mutant seen so far. This suggests that the aerobic class Ib RNR might be a good drug
target.
Even though NrdHEKF is a good drug target and S. sanguinis is highly
incapacitated, it is still unknown if the decrease in Mn from the ssaACB is due to
decreased RNR activity from the lack of Mn. It is entirely possible that Mn is needed for
another system or enzyme, besides RNR, that is the true reason why the decrease in
Mn causes a decrease in virulence. More work must be done to definitively say whether
RNR is or is not the true reason why the deletion of the Mn transporter, ssaACB, causes
a loss in virulence.
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